Inhibition of Methotrexate Uptake <i>via</i> Organic Anion Transporters OAT1 and OAT3 by Glucuronides of Nonsteroidal Anti-inflammatory Drugs-Reference-Cited by-同舟云学术

Inhibition of Methotrexate Uptake via Organic Anion Transporters OAT1 and OAT3 by Glucuronides of Nonsteroidal Anti-inflammatory Drugs

Published:2017 Issue:6 Volume:40 Page:926-931
ISSN:0918-6158
Container-title:Biological & Pharmaceutical Bulletin
language:en
Short-container-title:Biol. Pharm. Bull.

Author:

Iwaki Masahiro¹,Shimada Hiroaki¹,Irino Yuri¹,Take Manami¹,Egashira Sachiko¹

Affiliation:

1. Department of Pharmacy, Faculty of Pharmacy, Kindai University

Publisher

Pharmaceutical Society of Japan

Subject

Pharmaceutical Science,Pharmacology,General Medicine

Link

https://www.jstage.jst.go.jp/article/bpb/40/6/40_b16-00970/_pdf

Reference38 articles.

1. 1) Ellison NM, Servi RJ. Acute renal failure and death following sequential intermediate-dose methotrexate and 5-FU: a possible adverse effect due to concomitant indomethacin administration. Cancer Treat. Rep., 69, 342–343 (1985).

2. 2) Thyss A, Milano G, Kubar J, Namer M, Schneider M. Clinical and pharmacokinetic evidence of a life-threatening interaction between methotrexate and ketoprofen. Lancet, 327, 256–258 (1986).

3. 3) Cassano WF. Serious methotrexate toxicity caused by interaction with ibuprofen. Am. J. Pediatr. Hematol. Oncol., 11, 481–482 (1989).

4. 4) Singh RR, Malaviya AN, Pandey JN, Guleria JS. Fatal interaction between methotrexate and naproxen. Lancet, 1, 1390 (1986).

5. 5) Tracy TS, Krohn K, Jones DR, Bradley JD, Hall SD, Brater DC. The effects of a salicylate, ibuprofen, and naproxen on the disposition of methotrexate in patients with rheumatoid arthritis. Eur. J. Clin. Pharmacol., 42, 121–125 (1992).

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proteomic Profiling Reveals Age-Related Changes in Transporter Proteins in the Human Blood-Brain Barrier;2024-07-27

2. In Vivo Regulation of Small Molecule Natural Products, Antioxidants, and Nutrients by OAT1 and OAT3;Nutrients;2024-07-12

3. Utilising Endogenous Biomarkers in Drug Development to Streamline the Assessment of Drug–Drug Interactions Mediated by Renal Transporters: A Pharmaceutical Industry Perspective;Clinical Pharmacokinetics;2024-06

4. Enhancing the Efficacy and Safety of Methotrexate Treatment: A Focus on Drug Interactions (Review);Safety and Risk of Pharmacotherapy;2024-04-27

5. Risk factors associated with high-dose methotrexate induced toxicities;Expert Opinion on Drug Metabolism & Toxicology;2024-03-19